[Purulent meningitis. Considerations on the modern therapy, clinical course and prognosis with various germs].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000472:pathogenicity; D003295:Convulsive Therapy; D003348:Cortisone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008089:Listeria monocytogenes / Q000472:pathogenicity; D008297:Male; D008581:Meningitis / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology*; D008585:Meningitis, Meningococcal / Q000188:drug therapy*; D008586:Meningitis, Pneumococcal / Q000188:drug therapy*; D008875:Middle Aged; D011379:Prognosis; D013210:Staphylococcus / Q000472:pathogenicity; D013291:Streptococcus / Q000472:pathogenicity
D000900:Anti-Bacterial Agents; D003348:Cortisone
Die Meningitis purulenta. Betrachtungen über die moderne Therapie, Verlaufsformen und Prognose bei den verschiedenen Erregern.